allogenic mesenchymal stem cell derived from olfactory mucosa

Cell therapyexperimental

Clinical trial activity

5 trials · 6 clinical orgs · 0 marketing orgs

Phase 1
4
Phase 2
5
Phase 3
0
Phase 4
0

Earliest trial started Jan 3, 2017 (NCT03130374)

Timeline

2010s

  1. Jan 1, 2017

    Earliest Phase 1 Sponsor(trial)

2020s

  1. Jan 1, 2021

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

  • Unspecified targetTissue restoration

    Tissue restoration

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • olfactory mucosa-derived mesenchymal stem cells

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT05167552Phase 1/Phase 2 (Phase 2)Mar 1, 2022National Academy of Sciences of Belarus, The Republican Center for Research and Practice in Otolaryngology, Belarus
NCT05535803Phase 2Jun 1, 2021Government of Belarus, National Academy of Sciences of Belarus, The Republican Center for Research and Practice in Otolaryngology, Belarus
NCT04382547Phase 1/Phase 2 (Phase 2)May 11, 2020Belarusian State Medical University, Government of Belarus, National Academy of Sciences of Belarus
NCT04184258Phase 1/Phase 2 (Phase 2)Jul 1, 2019Belarusian State Medical University, National Academy of Sciences of Belarus
NCT03130374Phase 1/Phase 2 (Phase 2)Jan 3, 2017Belarusian Medical Academy of Post-Graduate Education, The Republican Center for Research and Practice in Otolaryngology, Belarus, The Republican Research and Practical Center for Epidemiology and Microbiology
Showing 5 of 5 trials
Page 1 / 1

Organizations

Research & Development (6)

6 organizations
Page 1 / 1